Evidence map›Paper›PMID 34957351›Full record

ArticleScientific African2022

Implications of WHO COVID-19 interim guideline 2020.5 on the comprehensive care for infected persons in Africa Before, during and after clinical management of cases.

Adeniyi Francis Fagbamigbe, Mai F Tolba, Ebenezer F Amankwaa, Priscilla Kolibea Mante, Augustina Angelina Sylverken, Julien Z B Zahouli, Nowsheen Goonoo, Lydia Mosi, Kolapo Oyebola, Damaris Matoke-Muhia and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific African, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Exploring Socioeconomic Factors Among Women Living with HIV in Malawi and Kenya.Journal of racial and ethnic health disparities · 2026
    Article
  2. Different COVID-19 treatments' impact on hospital length of stay.European journal of medical research · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 11 institutions in 7 countries.

Adeniyi Francis FagbamigbeThe African Academy of Sciences, Nairobi, Kenya.
Mai F TolbaThe African Academy of Sciences, Nairobi, Kenya.
Ebenezer F AmankwaaThe African Academy of Sciences, Nairobi, Kenya.
Priscilla Kolibea ManteThe African Academy of Sciences, Nairobi, Kenya.
Augustina Angelina SylverkenThe African Academy of Sciences, Nairobi, Kenya.
Julien Z B ZahouliThe African Academy of Sciences, Nairobi, Kenya.
Nowsheen GoonooThe African Academy of Sciences, Nairobi, Kenya.
Lydia MosiThe African Academy of Sciences, Nairobi, Kenya.
Kolapo OyebolaThe African Academy of Sciences, Nairobi, Kenya.
Damaris Matoke-MuhiaThe African Academy of Sciences, Nairobi, Kenya.
Dziedzom K de SouzaThe African Academy of Sciences, Nairobi, Kenya.
Kingsley BaduThe African Academy of Sciences, Nairobi, Kenya.
Natisha DukhiThe African Academy of Sciences, Nairobi, Kenya.
African Academy of Sciences · KEKwame Nkrumah University of Science and Technology · GHAin Shams University · EGHuman Sciences Research Council · ZAKenya Medical Research Institute · KEKumasi Centre for Collaborative Research in Tropical Medicine · GHNoguchi Memorial Institute for Medical Research · GHUniversité Alassane Ouattara · CIUniversity of Ghana · GHUniversity of Ibadan · NGUniversity of Mauritius · MU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The novel coronavirus disease 2019 (COVID-19) is one of the biggest public health crises globally. Although Africa did not display the worst-case scenario compared to other continents, fears were still at its peak since Africa was already suffering from a heavy load of other life-threatening infectious diseases such as HIV/AIDS and malaria. Other factors that were anticipated to complicate Africa's outcomes include the lack of resources for diagnosis and contact tracing along with the low capacity of specialized management facilities per capita

Indexed as

AFCOR, Africa Task Force for Novel CoronavirusAfricaAIDS, acquired immune deficiency syndromeARDS, acute respiratory distress syndromeC02, carbon dioxideClinical managementContact tracingCOVID-19ECMO, extracorporeal membrane oxygenationGGE, general government expenditureGGHE, general government health expenditureH2O, HydrogenHIV, Human immunodeficiency virusMERS, Middle East Respiratory SyndromeNHS, national health servicesO2, OxygenPCR, polymerase chain reactionPTSD, post-traumatic stress disorderRECOVERY, Randomized Evaluation of COVID-19 TherapySARS, severe acute respiratory syndromeStigmatizationUS-CDC, United States Centre for Disease ControlWHO guidelinesWHO, World Health Organization

Identifiers

PMID34957351
PMCPMC8683379
OpenAlexW4200620840

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.